SOLENO THERAPEUTICS INC's ticker is and the CUSIP is 834203309. A total of 26 filers reported holding SOLENO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,947,660 | +275.8% | 66,000 | -45.4% | 0.07% | +257.9% |
| Q2 2023 | $518,228 | -10.1% | 120,799 | -55.2% | 0.02% | -17.4% |
| Q1 2023 | $576,608 | +158.9% | 269,443 | +139.5% | 0.02% | +109.1% |
| Q4 2022 | $222,748 | +197.0% | 112,499 | +150.0% | 0.01% | +175.0% |
| Q3 2022 | $75,000 | – | 44,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sassicaia Capital Advisers LLC | 8,655 | $255,409 | 12.02% |
| Vivo Capital, LLC | 3,203,093 | $94,523,274 | 10.36% |
| Fairmount Funds Management LLC | 1,142,473 | $33,714,378 | 4.06% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 370,000 | $10,918,700 | 3.31% |
| COMMODORE CAPITAL LP | 887,500 | $26,190,125 | 3.06% |
| Perceptive Advisors | 3,074,542 | $90,729,734 | 3.03% |
| Carlyle Group Inc. | 2,293,562 | $67,430,723 | 2.92% |
| Ikarian Capital, LLC | 536,720 | $15,838,608 | 1.90% |
| Nantahala Capital Management | 392,404 | $11,579,842 | 0.99% |
| Frazier Life Sciences Management, L.P. | 464,937 | $13,720,291 | 0.91% |